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Abstract
Background: Cysteine cathepsins are known to primarily cleave their substrates at reducing and acidic conditions
within endo-lysosomes. Nevertheless, they have also been linked to extracellular proteolysis, that is, in oxidizing and
neutral environments. Although the impact of reducing or oxidizing conditions on proteolytic activity is a key to
understand physiological protease functions, redox conditions have only rarely been considered in routine enzyme
activity assays. Therefore we developed an assay to test for proteolytic processing of a natural substrate by cysteine
cathepsins which accounts for redox potentials and pH values corresponding to the conditions in the extracellular space
in comparison to those within endo-lysosomes of mammalian cells.
Results: The proteolytic potencies of cysteine cathepsins B, K, L and S towards thyroglobulin were analyzed under
conditions simulating oxidizing versus reducing environments with neutral to acidic pH values. Thyroglobulin, the
precursor molecule of thyroid hormones, was chosen as substrate, because it represents a natural target of cysteine
cathepsins. Thyroglobulin processing involves thyroid hormone liberation which, under physiological circumstances,
starts in the extracellular follicle lumen before being continued within endo-lysosomes. Our study shows that all
cathepsins tested were capable of processing thyroglobulin at neutral and oxidizing conditions, although these are
reportedly non-favorable for cysteine proteases. All analyzed cathepsins generated distinct fragments of thyroglobulin at
extracellular versus endo-lysosomal conditions as demonstrated by SDS-PAGE followed by immunoblotting or N-
terminal sequencing. Moreover, the thyroid hormone thyroxine was liberated by the action of cathepsin S at extracellular
conditions, while cathepsins B, K and L worked most efficiently in this respect at endo-lysosomal conditions.
Conclusion: The results revealed distinct cleavage patterns at all conditions analyzed, indicating compartment-specific
processing of thyroglobulin by cysteine cathepsins. In particular, proteolytic activity of cathepsin S towards the substrate
thyroglobulin can now be understood as instrumental for extracellular thyroid hormone liberation. Our study
emphasizes that the proteolytic functions of cysteine cathepsins in the thyroid are not restricted to endo-lysosomes but
include pivotal roles in extracellular substrate utilization. We conclude that understanding of the interplay and fine
adjustment of protease networks in vivo is better approachable by simulating physiological conditions in protease activity
assays.
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Background
Proteolytic processes are of vital importance due to the
irreversibility of peptide bond cleavage. Spatio-temporal
regulation of proteolysis is therefore of highest signifi-
cance in determining the fate of cells. To date more than
66.500 gene sequences have been annotated as coding for
proteolytic enzymes. The diversity of proteases is further
reflected in broad tissue-, compartment- and substrate
specificities. Most of all protease genes encode for serine
peptidases (~25.000 sequences), followed by metallo
(~23.000) and cysteine peptidases (~10.400) [1,2].
Because of this variety, one key issue of degradomics is to
investigate networks of proteases in order to explain dis-
tinct proteolytic functions in the spatio-temporal context
of substrate cleavage [3]. It is common practice to employ
proteolytic activity assays to achieve this goal.
In this report we focused on cysteine cathepsins B, K, L
and S, and analyzed their processing patterns using a nat-
ural substrate, thyroglobulin (Tg), while taking into
account the suspected redox- and pH values of the physi-
ological cleavage environments.
It has been shown before that the cysteine cathepsins B, K,
L and S are localized to the endo-lysosomal system of thy-
roid epithelial cells. Moreover, they are present at extracel-
lular locations such as the apical plasma membrane and
within the follicular lumen of the thyroid gland [4-9].
Generally, cysteine cathepsins of the papain superfamily
are well known to engage in bulk protein turnover at the
increasingly acidic pH values of endocytic compartments
[10]. Nevertheless, the proteolytic potency of cysteine
cathepsins towards peptidic or natural substrates has been
demonstrated to expand over a wide range including neu-
tral pH values [4,11,12]. In fact, cysteine cathepsins were
often accredited as extracellularly acting enzymes in vivo
(for reviews, see [10,13]). Diverse protocols are available
that describe methods to perform activity assays of
cysteine cathepsins at neutral conditions, usually after
activation of the proteases by incubation with reducing
agents [14-19]. In reality, however, the extracellular space
is not only a neutral but also an oxidizing environment, as
much as endosomes and lysosomes exhibit not only
acidic but also reducing conditions.
In this study, we have chosen redox-values of -220 mV to
mimic the reducing environment of the cysteine-rich
endosomes and lysosomes [20-22]. Moreover, endo-lyso-
somes are characterized by increasingly acidic conditions
[23-25], and we considered pH 6.0 and pH 5.0 as closely
reflecting the endosomal and lysosomal milieu, respec-
tively. On the other hand, the thyroid follicle lumen rep-
resents a secluded compartment in which the tight
junctions between thyroid epithelial cells tie up the extra-
cellular storage space for Tg from the intercellular spaces
between thyrocytes [26,27]. The follicle lumen is assumed
to be neutral in pH thereby rendering Tg proteolysis by
extracellular hydrolases unlikely (for reviews, see [26-
28]). However, more recently we provided evidence for Tg
proteolysis mediated by cysteine cathepsins within the
extracellular thyroid follicle lumen before its endocytosis
[6,7]. Extracellularly stored Tg of the human thyroid folli-
cle lumen is covalently cross-linked by disulfide bonds
[29] which can be formed in a self-assisted fashion via the
CXXC-boxes within Tg [30], thereby attesting an oxidizing
milieu within the thyroid follicle lumen. Furthermore, the
direct pericellular environment adjacent to the apical
plasma membrane of thyroid epithelial cells is oxidizing
due to the presence of an H2O2 generating system which
enables thyroid peroxidase to iodinate Tg at neutral pH
[31,32]. We have chosen a value of -150 mV to mimic the
extracellular space which is slightly more oxidizing than
the range of -160 mV to -170 mV that was reported for the
lumen of the endoplasmic reticulum [33].
As yet, there are only very few studies which consider
both, pH values and redox potentials of the cleavage envi-
ronment [21,34]. The assay described herein therefore
employs buffers accounting for the conditions in the fol-
licle lumen equivalent to the extracellular space or within
endo-lysosomal compartments. We assessed the suitabil-
ity of such buffers to promote proteolytic cleavage of Tg by
specific cysteine cathepsins in order to simulate proteoly-
sis within thyroid follicles, i.e. within an extracellular
compartment, or within the endo-lysosomes of thyrocytes
(Figure 1). Processing of Tg in the thyroid serves as an
excellent model system for our purposes, because it has
been demonstrated that (i) the cysteine cathepsins B, K, L
and S cleave Tg in vitro [4,35-38], (ii) Tg is located in all
compartments where cysteine cathepsins principally meet
their substrates, i.e. endosomes, lysosomes, and in the
extracellular space [[4,6-9], and this study], (iii) cysteine
cathepsins and Tg represent a naturally occurring and
physiologically relevant enzyme-substrate couple in vivo
[6,7]. Under physiological conditions, proteolysis of Tg
leading to thyroid hormone liberation is accomplished by
cysteine cathepsins in a sequential process starting with
the solubilization of Tg from its covalently cross-linked
macromolecular storage forms that fill the extracellular
follicle lumen. The initial substrate cleavage results in the
production of smaller protein fragments that are internal-
ized by thyroid epithelial cells together with partially
processed Tg [6,7]. Accordingly, liberation of the thyroid
hormones T3 and T4, which are essential for the regulation
of mammalian development and metabolism begins
extracellularly and is perpetuated within endocytic com-
partments of thyroid epithelial cells.
This study aims at elucidating crucial roles of selected
cysteine cathepsins in this sequence of prohormoneBMC Biochemistry 2009, 10:23 http://www.biomedcentral.com/1471-2091/10/23
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Figure 1
Schematic overview representing the organization of a thyroid follicle. The thyroid follicle lumen displays a pro-
tected extracellular compartment which is enclosed by a monolayer of thyroid epithelial cells interconnected by tight junctions.
The apical plasma membrane of thyrocytes faces the follicle lumen in which compacted and covalently cross-linked thyroglobu-
lin (Tg) is stored in globules reaching up to 150 m in diameter. Tg-globules are far too large to be engulfed by single thyro-
cytes on the whole, thus partial degradation in the extracellular follicle lumen must precede endocytosis. By limited
degradation, mediated by cysteine cathepsins within the pericellular space, Tg fragments are liberated and are subsequently
endocytosed for degradation in endosomes and lysosomes. Thyroxine liberation by processing of the prohormone Tg starts
extracellularly and is continued intracellularly after Tg-fragment internalization. Compartments in which proteolysis of Tg prin-
cipally takes place are highlighted and the chosen redox- and pH-conditions were used as indicated in the associated boxes (for
further details please refer to Background section).
processing. The development of an in vitro assay system
mimicking the in situ pH and redox conditions enabled
analysis of the potency of cathepsins B, K, L and S to cleave
their natural substrate Tg and to liberate thyroid hor-
mones under conditions simulating favorable (endo-lyso-
somal) versus non-favorable (extracellular)
compartments.
Results
Localization of cysteine cathepsins in the human thyroid 
gland
The subcellular localization of cysteine cathepsins has
been studied in detail in almost all tissues but not to the
same extent in the human thyroid gland. Therefore and in
order to analyze the distribution patterns of particular
cysteine cathepsins in the compartments of Tg processing,
human thyroid tissue was immunolabeled with antibod-
ies against cathepsins B, K, L, and S in single and double
labeling experiments. Cathepsins B, K, and L were co-BMC Biochemistry 2009, 10:23 http://www.biomedcentral.com/1471-2091/10/23
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Figure 2 (see legend on next page)BMC Biochemistry 2009, 10:23 http://www.biomedcentral.com/1471-2091/10/23
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localized within the same intracellular vesicles (Figure 2B
and 2D, yellow signals). Cathepsin S appeared to be also
localized to distinct vesicular compartments, because co-
localization with cathepsins K and L was not as prominent
(Figure 2A and 2C). Some cathepsin L-positive vesicles
were even lacking cathepsin S (Figure 2A, inset, arrow-
heads). Likewise, cathepsin K-positive structures were
often negative for cathepsin S (Figure 2C, inset, arrow-
heads). Consequently, cathepsin S-positive vesicles lack-
ing cathepsins K or L were frequently detected (Figure 2A
and 2C, insets, arrows). Moreover, all cathepsins analyzed
were detected in the extracellular space, i.e. within the fol-
licle lumen, indicating their secretion (Figure 2, arrows in
lumina labeled with asterisks). Note, that the extracellular
follicle lumen (Figure 2, asterisks) represents a storage
compartment for Tg, hence, all cathepsins are found in
close proximity to their natural substrate already here.
Cathepsin S was prominently present in the extracellular
follicle lumen (Figure 2A and 2C, arrows in lumina
labeled with asterisks). Cathepsins K and L were addition-
ally found pericellularly in close association with the api-
cal plasma membrane (Figure 2B and 2C, arrowheads),
where thyroid hormone liberation by Tg processing is
believed to start. We conclude that trafficking of proteases
in thyroid epithelial cells results in a distinct protease
composition within vesicles of the endocytic pathway in
addition to their secretion into the extracellular space.
Hence, it is important to analyze Tg processing with differ-
ent combinations of cysteine cathepsins and to simulate
substrate cleavage at the conditions of the respective com-
partments, i.e. extracellular follicle space, endosomes and
lysosomes.
Establishment of buffers with stable redox potentials at 
distinct pH values
Buffers representative for the extracellular space, the endo-
somal compartment and for lysosomes were established
through the use of a two-buffer system of citric acid,
sodium phosphate, and L-cysteine. In order to verify
buffer stability, the actual pH and redox values were deter-
mined for a minimum time period of 24 hours. The buffer
simulating extracellular conditions with an oxidizing
redox potential of -150 mV and neutral pH 7.2 was shown
to be stable over 24 hours (Figure 3A). Although addition
of Tg marginally lowered redox and pH values, the overall
stability under extracellular conditions was more stringent
in the presence of substrate (Figure 3B). Buffers mimick-
ing endosomes and lysosomes were adjusted to -220 mV
and differed from one another in their pH values, only.
The endosomal-representative buffer was set to pH 6.0
and the lysosomal to pH 5.0. The stability of these buffers
with respect to redox potential and pH value was verified
over a 4 h time period (Figure 3C and 3D) as these buffers
were stable from the very beginning.
Determination of cleavage sites within Tg
Isolated Tg was incubated with cathepsins in buffers sim-
ulating extracellular conditions and the extent of substrate
cleavage was compared to that achieved under conditions
characteristic for intracellular proteolysis within endo-lys-
osomal compartments. Cathepsins B, K, L and S or com-
binations thereof were incubated with Tg in the respective
buffers and proteolysis was allowed to occur for 2 hours.
Preparations were then heated in LDS sample buffer with-
out any further addition of reducing agents. This proce-
dure ensured consistent behavior of all samples from the
same conditions upon separation by PAGE since they
were run on separate gels. Fragmentation patterns were
analyzed by SDS-PAGE followed by immunoblotting
using antibodies specific for Tg (Figure 4) and by N-termi-
nal sequencing of selected Tg-fragments (Figure 5). Note,
that for all incubations an identical amount of Tg was sub-
jected to cysteine cathepsin degradation, whereby the par-
ticular amount of distinct enzymes was kept constant in
all incubations. Therefore, the ratios of total enzyme to
substrate differed between single and combinatorial incu-
bations (see also Materials and Methods). We were espe-
cially decided about such conditions, because we consider
this setup to best reflect Tg cleavage in situ. As we have
shown in the localization studies (see Figure 1), vesicles
may contain only one type of enzyme or combinations of
different enzymes. For the extracellular follicle lumen,
similar approximations might be relevant, since we
observed almost no co-localization of the distinct cysteine
Localization of cysteine cathepsins in human thyroid tissue Figure 2 (see previous page)
Localization of cysteine cathepsins in human thyroid tissue. Multi-channel fluorescence (A-D and insets), single chan-
nel and corresponding phase contrast micrographs (black and white) of cryo-sections taken from human thyroid tissue that 
were immunolabeled with antibodies directed against cysteine cathepsins B, K, L, or S in different combinations, as indicated. 
Co-localization is displayed by yellow signals as a result of overlapping red and green signals for either antibody labeling. Cathe-
psins B and K as well as K and L were mainly co-localized to the same intracellular compartments (B and D, insets, arrows), 
whereas cathepsin S was found in structures that were lacking other cysteine cathepsins (A and C, insets, arrows). Likewise, 
vesicles containing only cathepsin L or K (A and C, insets, arrowheads) were also prominent. All cysteine cathepsins were 
present within the Tg-containing extracellular follicle lumen (asterisks, Tg) where no co-localization of either cysteine cathep-
sin with one another was detectable. Cathepsins K and L were further detected in association with the apical plasma mem-
brane of thyrocytes (B and C, insets, arrowheads). Bars represent 50 m.BMC Biochemistry 2009, 10:23 http://www.biomedcentral.com/1471-2091/10/23
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cathepsins in the extracellular space, but different
enzymes were detectable and can therefore, in principle,
cleave luminal Tg. Hence, the observed degradation pat-
terns must be interpreted as resulting from different com-
binations of enzymes acting sequentially and/or at the
same time on Tg.
Under neutral and oxidizing conditions mimicking the
extracellular thyroid follicle lumen full-length Tg of
approximately 330 kDa was cleaved by each of the
cysteine cathepsins tested, even though these buffer con-
ditions are considered as 'non-favorable' for proteolytic
action of cysteine cathepsins (Figure 4A). The effective-
ness of substrate-cleavage was obvious from the appear-
ance of two fragments of approximately 250 and 200 kDa
(Figure 4A, arrowheads), which were also detected when
the assay buffers reflected more favorable endosomal
cleavage conditions, i.e. a reducing and slightly acidic
environment (Figure 4B, arrowheads). In addition to the
high molecular mass fragments, all samples containing
cathepsin S displayed a specific 70 kDa fragment under
extracellular conditions (Figure 4A, arrow). The same-
sized fragment was generated at conditions characteristic
for endosomes and lysosomes by several combinations of
Stability of assay buffers Figure 3
Stability of assay buffers. Redox potentials [mV] (open squares) and pH values (filled circles) were measured for the indi-
cated time intervals. A two-buffer system of citric acid and sodium phosphate was used to adjust the desired pH values while 
the redox values were adjusted by the addition of L-cysteine. Timepoint [t = 0] reflects the initially adjusted value; the setpoint 
of the redox potential is given as dashed line. Redox values above the setpoint are considered more oxidizing, whereas changes 
towards the negative potential are more reducing. Buffers representative for the extracellular space, i.e. mimicking an oxidizing 
(-150 mV) and neutral (pH 7.2) compartment, were measured in the absence (A) or presence (B) of the substrate Tg. Buffers 
mimicking the endosomal compartment were characterized by reducing (-220 mV) and slightly acidic (pH 6.0) conditions (C). 
Buffers representing the lysosomes displayed the same reducing redox-conditions as endosomes (c.f. C), but were more acidic 
(pH 5.0) (D). Values are given as mean +/- SD.BMC Biochemistry 2009, 10:23 http://www.biomedcentral.com/1471-2091/10/23
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Figure 4
Cleavage efficiency of cysteine cathepsins at distinct subcellular conditions. Single cathepsins or combinations
thereof were incubated with thyroglobulin (Tg) in vitro in buffers representative of extracellular conditions (A), endosomes (B)
or lysosomes (C) for 2 hours at 40°C. As a control, purified Tg was incubated in the respective buffers without proteases (A-
C, last lanes). Samples were PAGE-separated and Tg fragments were visualized by immunoblotting. Efficiency of cleavage at
neutral and oxidizing conditions was indicated by the appearance of a 250 kDa and a 200 kDa fragment (A, arrowheads). Simi-
lar fragments were observed under endosome-representative conditions (B, arrowheads). Most effective substrate degrada-
tion, discernible by numerous low molecular weight fragments, was observed under reducing, acidic conditions mimicking
lysosomes (C). Cathepsin L can be considered most effective in Tg-processing within the lysosomal compartment, because
samples containing this protease (C, asterisks) featured numerous low molecular weight fragments (arrows) and almost lacked
intact, full-length Tg (dashed arrow). Note, that under neutral and oxidizing conditions, cathepsin S qualified to be most effec-
tive in Tg-processing. All samples including this protease featured a specific 70 kDa fragment (A, arrow) additionally to higher
molecular mass products. In contrast to extracellular or lysosomal conditions, all peptidases tested performed equally well at
endosome-representative conditions.
cysteine cathepsins but notably not by cathepsin K alone
or in combination with cathepsins L and S. The analysis of
degradation patterns using assay conditions mimicking
lysosomal cleavage revealed a number of low molecular
mass fragments of Tg as generated by all cathepsin combi-
nations (Figure 4C, arrows). Samples containing cathep-
sin L lacked the intact, full-length Tg (Figure 4C, dashed
arrow), but contained numerous smaller fragments of 40-
70 kDa (Figure 4C, asterisks). Note that all preparations
contained equal amounts of Tg at the start of incubation
with cysteine cathepsins under different conditions. The
lanes were loaded after the incubation period with identi-
cally sized aliquots from each preparation. Hence, the
absence of signal in certain lanes of the immunoblots is
representative of extensive Tg degradation rather than
being the result of unequal loading of the gels. Accord-BMC Biochemistry 2009, 10:23 http://www.biomedcentral.com/1471-2091/10/23
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Figure 5 (see legend on next page)
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DMMIFDLVHSYNRFPDAFVTFSSFQRRFPEVSGYCHCADSQGRELAETGLELLLDEIYDTIFAGLDLPSTFTETTLYRILQRRFLAVQSVISGRFRCPTK 300
CEVERFTATSFGHPYVPSCRRNGDYQAVQCQTEGPCWCVDAQGKEMHGTRQQGEPPSCAEGQSCASERQQALSRLYFGTSGYFSQHDLFSSPEKRWASPR 400
VARFATSCPPTIKELFVDSGLLRPMVEGQSQQFSVSENLLKEAIRAIFPSRGLARLALQFTTNPKRLQQNLFGGKFLVNVGQFNLSGALGTRGTFNFSQF 500
FQQLGLASFLNGGRQEDLAKPLSVGLDSNSSTGTPEAAKKDGTMNKPTVGSFGFEINLQENQNALKFLASLLELPEFLLFLQHAISVPEDVARDLGDVME 600
TVLSSQTCEQTPERLFVPSCTTEGSYEDVQCFSGECWCVNSWGKELPGSRVRGGQPRCPTDCEKQRARMQSLMGSQPAGSTLFVPACTSEGHFLPVQCFN 700
SECYCVDAEGQAIPGTRSAIGKPKKCPTPCQLQSEQAFLRTVQALLSNSSMLPTLSDTYIPQCSTDGQWRQVQCNGPPEQVFELYQRWEAQNKGQDLTPA 800
KLLVKIMSYREAASGNFSLFIQSLYEAGQQDVFPVLSQYPSLQDVPLAALEGKRPQPRENILLEPYLFWQILNGQLSQYPGSYSDFSTPLAHFDLRNCWC 900
VDEAGQELEGMRSEPSKLPTCPGSCEEAKLRVLQFIRETEEIVSASNSSRFPLGESFLVAKGIRLRNEDLGLPPLFPPREAFAEQFLRGSDYAIRLAAQS 1000
TLSFYQRRRFSPDDSAGASALLRSGPYMPQCDAFGSWEPVQCHAGTGHCWCVDEKGGFIPGSLTARSLQIPQCPTTCEKSRTSGLLSSWKQARSQENPSP 1100
KDLFVPACLETGEYARLQASGAGTWCVDPASGEELRPGSSSSAQCPSLCNVLKSGVLSRRVSPGYVPACRAEDGGFSPVQCDQAQGSCWCVMDSGEEVPG 1200
TRVTGGQPACESPRCPLPFNASEVVGGTILCETISGPTGSAMQQCQLLCRQGSWSVFPPGPLICSLESGRWESQLPQPRACQRPQLWQTIQTQGHFQLQL 1300
PPGKMCSADYAGLLQTFQVFILDELTARGFCQIQVKTFGTLVSIPVCNNSSVQVGCLTRERLGVNVTWKSRLEDIPVASLPDLHDIERALVGKDLLGRFT 1400
DLIQSGSFQLHLDSKTFPAETIRFLQGDHFGTSPRTWFGCSEGFYQVLTSEASQDGLGCVKCPEGSYSQDEECIPCPVGFYQEQAGSLACVPCPVGRTTI 1500
SAGAFSQTHCVTDCQRNEAGLQCDQNGQYRASQKDRGSGKAFCVDGEGRRLPWWETEAPLEDSQCLMMQKFEKVPESKVIFDANAPVAVRSKVPDSEFPV 1600
MQCLTDCTEDEACSFFTVSTTEPEISCDFYAWTSDNVACMTSDQKRDALGNSKATSFGSLRCQVKVRSHGQDSPAVYLKKGQGSTTTLQKRFEPTGFQNM 1700
LSGLYNPIVFSASGANLTDAHLFCLLACDRDLCCDGFVLTQVQGGAIICGLLSSPSVLLCNVKDWMDPSEAWANATCPGVTYDQESHQVILRLGDQEFIK 1800
SLTPLEGTQDTFTNFQQVYLWKDSDMGSRPESMGCRKDTVPRPASPTEAGLTTELFSPVDLNQVIVNGNQSLSSQKHWLFKHLFSAQQANLWCLSRCVQE 1900
HSFCQLAEITESASLYFTCTLYPEAQVCDDIMESNAQGCRLILPQMPKALFRKKVILEDKVKNFYTRLPFQKLMGISIRNKVPMSEKSISNGFFECERRC 2000
DADPCCTGFGFLNVSQLKGGEVTCLTLNSLGIQMCSEENGGAWRILDCGSPDIEVHTYPFGWYQKPIAQNNAPSFCPLVVLPSLTEKVSLDSWQSLALSS 2100
VVVDPSIRHFDVAHVSTAATSNFSAVRDLCLSECSQHEACLITTLQTQPGAVRCMFYADTQSCTHSLQGQNCRLLLREEATHIYRKPGISLLSYEASVPS 2200
VPISTHGRLLGRSQAIQVGTSWKQVDQFLGVPYAAPPLAERRFQAPEPLNWTGSWDASKPRASCWQPGTRTSTSPGVSEDCLYLNVFIPQNVAPNASVLV 2300
FFHNTMDREESEGWPAIDGSFLAAVGNLIVVTASYRVGVFGFLSSGSGEVSGNWGLLDQVAALTWVQTHIRGFGGDPRRVSLAADRGGADVASIHLLTAR 2400
ATNSQLFRRA VLMGGSALSPAAVISHERAQQQAIALAKEVSCPMSSSQEVVSCLRQKPAN VLNDAQTKLLAVSGPFHYWGPVIDGHFLREPPARALKRSL 2500
WVEVDLLIGSSQDDGLINRAKAVKQFEESRGRTSSKTAFYQALQNSLGGEDSDARVEAAATWYYSLEHSTDDYASFSRALENATRDYFIICPIIDMASAW 2600
AKRARGNVFMYHAPENYGHGSLELLADVQFALGLPFYPAYEGQFSLEEKSLSLKIMQYFSHFIRSGNPNYPYEFSRKVPTFATPWPDFVPRAGGENYKEF 2700
SELLPNRQGLKKADCSFWSKYISSLKTSADGAKGGQSAESEEEELTAGSGLREDLLSLQE PGSKTYSK 2768
A
signal peptide extracellular
endosomal lysosomal
Y
Y
hormogenic site (T4)
hormogenic site (T3)
Adopted from Dunn et al. [Ref. 36-37]BMC Biochemistry 2009, 10:23 http://www.biomedcentral.com/1471-2091/10/23
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ingly, blank or weakly labeled lanes indicate complete
degradation of Tg by the respective cysteine cathepsin/s at
these conditions. As a control of its stability, Tg was incu-
bated in the respective buffers, but without any protease
added (Figure 4A-C, last lanes).
In order to determine the cleavage sites that were used by
cysteine cathepsins, characteristic Tg fragments were N-
terminally sequenced (Figure 5). A band with a molecular
mass of approximately 330 kDa exhibited the same N-ter-
minus as unprocessed Tg in all instances, thus represent-
ing intact, full-length protein. Tg-fragments originating
from proteolytic processing by cathepsin S under extracel-
lular conditions had molecular masses of approximately
200 kDa, 170 kDa and 70 kDa. Two of these fragments
exhibited newly generated N-termini, while the 70 kDa
fragment showed the same N-terminus as unprocessed Tg.
Arrowheads indicate relative positions of identified cleav-
age sites as deduced from N-terminal sequencing of extra-
cellular- (Figure 5B) or endosomal-like Tg degradation
(Figure 5C). In Figure 5D a scheme of lysosomal cleavage
sites is depicted, which was determined by Dunn and col-
leagues [36,37] under near-physiological conditions since
lysosomal extracts were used to degrade Tg. The schematic
drawings in Figure 5 illustrate that the cleavage sites varied
within Tg depending on the conditions under which
cleavage took place.
Analysis of physiological significance of Tg cleavage
Determination of cathepsin cleavage sites revealed that
the N-terminal half of Tg was prone to extracellular and
endosomal cleavage, whereas the thyroid hormone-rich
C-terminal half is, according to [36,37], best cleaved
under conditions of lysosomal Tg processing. In order to
implement a physiologically relevant read-out for effi-
ciency of substrate cleavage, we analyzed the in vitro-deg-
radation samples for their content of liberated, free
thyroxine (fT4) by ELISA. Under extracellular conditions,
fT4 was only detected in samples that contained cathepsin
S alone or in combinations with other cathepsins (Figure
6A). Under endosomal conditions, the overall efficiency
of fT4 liberation was considerable, about 70 fold higher
than compared to extracellular conditions with values of
fT4 ranging from approximately 35 to 55 pM (Figure 6B).
Yet, another augmentation in the amount of liberated T4
was observed under conditions simulating lysosomes
where cathepsins B, K and L performed equally well by
liberating T4 in a range from 75 to 100 pM (Figure 6C).
Discussion
One important mechanism to control protease activity is
given by endogenous inhibitors, another is represented by
the dependency of proteolytic enzymes on the pH and
redox potential of the cleavage environment. Whereas pH
sensitivity has been studied quite extensively (for review,
see [39]), much less is known about their sensitivity to the
redox potential of the environment. Endo-lysosomal
cysteine proteases like cathepsins L and B are considered
highly instable at neutral pH values with half lives of 1.3
and 15 minutes, respectively [40,41]. The inactivation
appears to be irreversible and is associated with a loss of
native 3D structure. However, a few other cysteine cathe-
psins of the papain superfamily clan C1A display pro-
longed stability and activity at neutral pH values,
cathepsins K and S are the most prominent examples
[4,11,18]. In contrast, papain as well as cruzain exhibit
stability at broad ranges of pH values and withstand neu-
tral to even basic pH-conditions [42,43]. On the other
hand, other plant proteases are particularly prone to turn
instable at pH values differing from their acidic optimum
[43]. These pronounced differences in the pH-dependent
stability indicate that papain-like enzymes have evolved
[44,45] to play roles in a variety of biological processes,
bringing proteolysis into milieus outside acidic endo-lys-
osomal compartments. Therefore, mammalian cysteine
cathepsins might be the "specialists" in acidic environ-
Preferential cleavage sites for cysteine cathepsins within the thyroglobulin sequence at distinct redox- and pH-conditions Figure 5 (see previous page)
Preferential cleavage sites for cysteine cathepsins within the thyroglobulin sequence at distinct redox- and pH-
conditions. Characteristic Tg-fragments obtained by in vitro degradation at extracellular or intra-endo-lysosomal conditions 
were N-terminally sequenced. Newly generated N-termini are highlighted (A); box colors represent the respective condition 
at which fragments were obtained (c.f. Figure 1). Hormogenic sites, i.e. pre-formed thyroid hormones tri-iodothyronine (T3) 
and thyroxine (T4), are tagged in blue and green; the signal peptide is highlighted in grey. (B-D) Schematic drawings sketch the 
Tg molecule that comprises Tg Type I domains (green), Type II (blue), Type III A (light grey), Type III B repeats (dark grey), 
Thyropins (red), and CXXC-motifs (see [6] for details). Arrowheads indicate relative positions of identified cleavage sites uti-
lized in extracellular- (B) or endosomal-like Tg processing (C). Cleavage sites of cathepsins B, D, and L were determined by N-
terminal sequencing of Tg fragments derived from incubation of rabbit Tg with lysosomal extracts or cathepsins isolated from 
human thyrocytes (D; according to [36,37]). This scheme (D) is shown for comparison, only, and shaded to indicate that it is 
adopted (see [6]) from the results of studies performed by Dunn and co-workers [36,37]. Corresponding cysteine cathepsins 
or combinations thereof are given below the arrowheads; the respective neo-N-termini are specified above the representative 
schematic drawing. Arrows in B and D indicate similar cleavage sites under extracellular conditions and within lysosomes, 
respectively.BMC Biochemistry 2009, 10:23 http://www.biomedcentral.com/1471-2091/10/23
Page 10 of 15
(page number not for citation purposes)
ments, although they are still suited to perform their
actions, at least temporarily, under the neutral pH-condi-
tions of the extracellular space that are nowadays consid-
ered non-favorable or even "extreme" [5,10,46].
In fact, proteolytic activity of lysosomal cysteine pepti-
dases in an environment exhibiting conditions opposite
to the reducing and acidic milieu of endo-lysosomal com-
partments was not long ago considered to be a mission
impossible. Oxidizing conditions enforce the formation
of disulfide bonds by reactive thiol groups which makes
the active site cysteine of cathepsins highly sensitive to
oxidation. Thus, under reducing conditions, like it is
assumed for the endo-lysosomal compartment, the activ-
ity of cysteine cathepsins should be considerably higher
than in other compartments exhibiting oxidizing condi-
tions, like e.g. the extracellular space. In the thyroid, how-
ever, the extracellular follicle lumen is the scene of action
for the initial steps of thyroid hormone utilization, i.e. the
solubilization of covalently cross-linked Tg and thyroxine
liberation by proteolytic processing mediated primarily
through cysteine cathepsins B, K, L and S [7].
Up to now, the hypothesis that cysteine peptidases hold
proteolytic activity in oxidizing environments was rarely
challenged experimentally due to the lack of suitable
activity assays with conditions mimicking the in vivo situ-
ation in the most life-like fashion, i.e. at realistic pH and
redox conditions in physiological settings. In situ, redox
conditions in cellular compartments or in the extracellu-
lar space are achieved and maintained by redox pairs of
which cysteine(Cys)-cystine(CySS) constitutes the promi-
nent and natural redox-pair of the extracellular space and
endo-lysosomal compartments [47]. In keeping with this
notion, exact values describing redox potentials are aston-
ishingly scarce and have been reported for the cytosol (-
221 mV to -236 mV) and the ER lumen (-160 mV to -170
Figure 6
Cysteine cathepsins efficiency to liberate thyroxine (T4) in  vitro Figure 6
Cysteine cathepsins efficiency to liberate thyroxine 
(T4) in vitro. Samples taken after 2h-in-vitro-degradation of 
Tg were assayed for their content in free thyroxine (fT4) by 
ELISA. Efficiency of hormone liberation by distinct cysteine 
cathepsins or combinations thereof is directly correlated to 
the amount of fT4. Under conditions mimicking the extracel-
lular space, exclusively cathepsin S proved to be efficient in 
thyroxine liberation (A), whereas under endosomal-repre-
sentative conditions all cysteine cathepsins performed equally 
well (B). The same holds true for conditions mimicking the 
lysosomal compartment, although cathepsin S was less active 
as reflected by lower thyroxine liberation potency as com-
pared with e.g. cathepsin B (C). Highest amounts of fT4 were 
measured for lysosomal-mimicking environments, followed 
by those performed under conditions simulating endosomes 
and the extracellular space (A-C). Values are given as mean 
values +/- SD.BMC Biochemistry 2009, 10:23 http://www.biomedcentral.com/1471-2091/10/23
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mV) [21,22,33]. The latter represents an oxidizing intrac-
ellular compartment of protein folding in which disulfide
bridges are formed and maintained, whereas the cytosol is
clearly reducing. For the choice of our buffer system we
used the (Cys)-(CySS) redox-pair to adjust the redox
potential and we considered a redox potential of -220 mV
suitable to simulate reducing conditions of endosomes
and lysosomes. A redox value of -150 mV was adjusted for
mimicking the extracellular space, i.e. we assumed a
slightly more oxidizing milieu for the extracellular space
than that observed for the ER lumen. Through the use of
a two-buffer system with citric acid and sodium phos-
phate and through the addition of L-cysteine, we have
established buffers with stable redox potentials at distinct
pH values for in vitro analyses of proteolytic substrate
processing potency.
Another critical factor in proteolytic profiling is the choice
of substrate. Commonly, small synthetic substrates are
used for standard protease activity assays. More recently it
became mandatory to use natural substrates in in vitro
assays to collect more appropriate data; especially consid-
ering that protease-substrate interaction may also affect
enzyme activity [3]. The cleavage of Tg by cathepsins is a
naturally occurring process of high physiological impor-
tance [7], which makes Tg an excellent substrate in our
proteolytic assays. The partial degradation of extracellu-
larly stored full-length Tg within the thyroid follicle
lumen is of great importance in vivo. It represents the nec-
essary first step to produce smaller fragments of the pro-
hormone that can easily be endocytosed to ensure endo-
lysosomal processing and efficient thyroid hormone liber-
ation. In the in vitro assay presented herein, partial prote-
olytic processing of full length Tg was achieved by all
cathepsins, resulting in the generation of three distinct
fragments even at neutral and oxidizing conditions. The
abundance of low molecular mass Tg-fragments in lyso-
somal-mimicking conditions of this assay must be consid-
ered representative of an extensive overall cleavage of the
substrate. It can therefore be deduced that all cysteine
cathepsins tested exhibited highest proteolytic activities,
indeed, under acidic and reducing conditions. This notion
is in line with the catabolic function of cysteine cathepsins
in situ which is mainly conducted within the endo-lyso-
somal compartment. We consider cathepsin L as the most
potent peptidase to catabolize Tg within the lysosomes,
because the respective samples lacked full-length, intact
Tg almost entirely, but contained numerous smaller frag-
ments of 40-70 kDa.
The application of several cathepsins at once proved to be
efficient in well-directed substrate cleavage further
strengthening results from our previous in vivo studies in
which it was shown that a concerted action of cathepsins
K and L is needed for T4 liberation in vivo [7]. The results
presented herein further support the conclusion that Tg-
processing and thyroid hormone liberation is achieved by
proteases acting consecutively towards efficient pro-hor-
mone utilization. Cathepsin S proved to be the best-suited
cysteine cathepsin to extracellularly liberate T4 from Tg,
i.e. to conduct hormone liberation before the pro-hor-
mone eventually reached endosomes and lysosomes.
Cathepsin S was also able to liberate T4 under endosomal
and lysosomal conditions, but then, it was not any more
efficient than the other cysteine cathepsins tested. In fact,
it has been shown that cathepsin S is the only cysteine
cathepsin which is truly stable at neutral pH when ana-
lyzed under reducing conditions, whereas cathepsins K
and L are unstable and cathepsin B exhibits limited stabil-
ity at reducing and neutral pH conditions
[11,17,18,40,41,48]. Interestingly, an additional cleavage
site for the combination of cathepsins K and S was deter-
mined within the N-terminal half of Tg at extracellular
conditions as compared to cleavage by cathepsin S alone
(Figure 5B). This might explain why liberation of T4 under
these conditions was less effective when both, cathepsins
K and S were used in contrast to combinations of cathep-
sin S with cathepsins B or L, in which the cathepsin S abil-
ity to utilize T4 from Tg clearly dominated (Figure 6A).
However, it should be kept in mind that the assay condi-
tions as presented herein differ significantly from those of
previous studies in that we mimicked physiological con-
ditions by testing cysteine cathepsins under oxidizing and
neutral pH conditions. Therefore, our results gained by
studying cleavage of their natural substrate Tg under such
comparatively "extreme" non-favorable conditions clearly
differ from the standard assay conditions in which the
read-out is not physiological, but instead cleavage of syn-
thetic substrates is monitored. Hence, we believe that the
data presented here has to be interpreted on the back-
ground of physiological protein processing with the bio-
logically significant read-out, that is, utilization of T4 by
processing of the precursor Tg.
None of the cleavage sites used by any of the cysteine
cathepsins tested was identical in both, extracellular and
endosomal conditions, i.e. in the compartments of well-
directed substrate processing. Thus, we conclude that pref-
erential cleavage is largely up to the compartment in
which substrate processing takes place. The presence of
different sets of proteolytic enzymes in such compart-
ments may allow for a combinatorial and sequential sub-
strate cleavage. This is to say that specific cleavage sites are
used in distinct environments, which provide stable, bio-
chemically defined conditions for specific sets of
enzymes, but do not necessarily exhibit the most favora-
ble conditions for bulk proteolytic processing. This notion
is further supported by comparative analysis of endo-
somal-typical cleavage with respect of lysosomal-typical
cleavage sites, which completely lack analogies as hasBMC Biochemistry 2009, 10:23 http://www.biomedcentral.com/1471-2091/10/23
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been determined by us (this study) and by Dunn and co-
workers using isolated cathepsins or extracts of thyroid
lysosomes [36,37]. Even though the cysteine cathepsins B
and L were included in both studies, only one cleavage-
site (Figure 5B and 5D, arrows) was found to be alike in
extracellular conditions (this study) and in Tg fragments
identified in lysosomal extracts (studies by Dunn and col-
leagues [36,37]). Interestingly, this particular cleavage site
was not reproduced by identical cathepsins in different
environments, but the extracellular-representative cleav-
age of Tg by cathepsin S (this study) generated an almost
identical neo-N-terminus as the cathepsin B-mediated
cleavage determined by Dunn and co-workers [36,37].
Thus, although the amino acid sequence of the substrate
itself predominantly dictates its cleavage, the specificity of
substrate cleavage is additionally directed by the biochem-
ical environment of cleavage and by the set of actually
cleaving enzymes.
It is important to keep in mind that the extracellularly act-
ing cysteine cathepsins in the thyroid follicle are derived
from their secretion into the follicle lumen after being
recruited out of endo-lysosomal compartments [9]. It is
generally accepted that the proteolytic activity of such
already activated cysteine peptidases can be maintained
under oxidizing conditions in the extracellular space for
longer time intervals [10,34,49]. Since the proteolytic
enzymes cleaving Tg in the thyroid follicle lumen have
experienced a reducing and acidic environment for proper
processing and activation before being secreted, they may
as well contribute significantly to physiological thyroid
hormone liberation by extracellular proteolysis of Tg.
Conclusion
Our study shows that a specific subcellular location is the
key figure in the nature of proteolytic processing, i.e. tim-
ing and location of peptidase activities determine whether
bulk protein turnover or, instead, specific substrate
processing takes place. Importantly enough, the onset of
many pathological processes like tumor cell metastasis,
rheumatoid arthritis, pancreatitis or multiple sclerosis
goes along with alterations in the patterns of cysteine
cathepsin localization and with pericellular acidification
which may well be suited to prolong the extracellular
actions of these proteases (for reviews see [10,13,50]).
The routine to analyze cysteine cathepsin-mediated
processing of Tg presented herein will be easily adaptable
to investigate any protease's proteolytic potential towards
any natural or artificial substrate. Hence, our approach is
applicable in order to study the degradome in a physio-
logical context at simulated in vivo conditions. By adapt-
ing our assay system to other proteases, we anticipate a
better understanding of the interplay and fine-adjust-
ments of protease-networks that control substrate process-
ing in the determination of 'vital' or 'fatal' changes in
cellular destiny. Comprehensive knowledge of proteolysis
in physiological or pathological conditions, in turn, is
critical for the development of effective treatments and
novel therapeutics.
Methods
Depletion of non-covalently associated T4 from isolated 
human Tg
Purified human Tg [29,51] was mixed with 200 g/mL 8-
anillino-1-naphtalene-sulfonic acid ammonium salt
(ANS, Calbiochem/Merck, Darmstadt, Germany) and
incubated on an end-over-end-rotator (14 rpm) for 1 h in
order to dissociate non-covalently bound T4 from its pre-
cursor that is known to eventually function as a T4-bind-
ing protein. The mixture was cleared of free T4 by two
subsequent incubations with an anion exchange resin,
DOWEX 1 (1 × 8 chloride form, 200-400 mesh; 50 mg/
mL; Sigma, Munich, Germany). The crude and fine resin
parts were removed by two centrifugation steps at 1,000
and 30,000 × g for 10 and 20 minutes, respectively. Super-
natants were used for protein determination according to
Neuhoff [52].
Preparation of assay buffers
A two-component buffer system of (A) 200 mM citric acid
and (B) 200 mM dibasic sodium phosphate was used.
Specific volumes of (A) and (B) were mixed as indicated
below and buffers were pre-warmed to 40°C (according
to [14]) while constantly stirring. Redox potentials were
adjusted by the addition of L-cysteine (Roth, Karlsruhe,
Germany) in the indicated amounts. Adequacy and stabil-
ity of pH and redox values were constantly monitored
using a pH electrode (SenTix 81) and an electrode for
redox control (SenTix ORP), both connected to an InoLab
pH Level 1 (all WTW, Weilheim, Germany). The pH of 7.2
in the buffer simulating the extracellular space was
achieved by mixing 6.9 mL of buffer A and 87.1 mL of
buffer B. Upon the addition of 9.58 mg L-cysteine the
redox potential of the buffer shifted to -150 mV. The buff-
ers mimicking slightly acidic endosomal compartments
(pH 6.0, -220 mV) and acidic lysosomal compartments
(pH 5.0, -220 mV) were prepared by mixing 19.7 mL of
buffer A and 68.3 mL of buffer B with 190 mg L-cysteine,
or 28 mL of buffer A with 65.5 mL of buffer B and 2.2 g L-
cysteine, respectively. Buffers were equilibrated at assay
temperature before use.
In vitro Tg degradation assay
Cathepsins B and L, purified from human liver, were pur-
chased from Calbiochem (Darmstadt, Germany), whereas
human cathepsins K and S were recombinant enzymes
[11,18]. Human Tg and single cathepsins or combina-
tions thereof were mixed in 100 L of buffers mimicking
extracellular, endosomal or lysosomal conditions to aBMC Biochemistry 2009, 10:23 http://www.biomedcentral.com/1471-2091/10/23
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final concentration of 9.5 pM for Tg, and 4.75 pM of
either of the cathepsins. Therefore, the substrate to pepti-
dase ratios varied from 1:0.5 up to 1:2 in single, double,
triple, and quadruple cathepsin combinations. Samples
were prepared in LowBind protein tubes (Eppendorf,
Hamburg, Germany), spun down and incubated on an
end-over-end rotator (40 rpm) for 2 hours at 40°C in a
heated incubator. Then, samples were briefly centrifuged
and processing of Tg was stopped either by freezing 50 L
aliquots of the samples at -20°C or by direct preparation
of the samples for subsequent SDS-PAGE analysis. Sam-
ples were mixed with lithium dodecyl sulfate (LDS) sam-
ple buffer, heated to 70°C for 10 minutes, and 50 L of
each individual sample was loaded per lane. Gel-electro-
phoresis was performed in an XCell SureLock Mini-Cell
using pre-cast 3-8% NuPAGE Novex Tris-Acetate gels and
NuPAGE Tris-Acetate SDS running buffer (all Invitrogen,
Karlsruhe, Germany) at 150 V for 75 minutes at RT. To
ensure consistent running behavior, gels were loaded with
samples from either of the three conditions so that reduc-
ing and non-reducing samples would not affect each other
during separation. Subsequently, Tg and fragments were
blotted onto polyvinylidenfluoride (PVDF) membranes at
30 V for 60 minutes using the XCell II Blotting Module
and NuPAGE transfer buffer (all Invitrogen) according to
the manufacturer's instructions.
Immunodetection of Tg and its degradation fragments
Membranes were blocked using 5% non-fat milk powder
in PBS-Tween (0.34 M NaCl, 0.316 M Na2HPO4, 58.49
NaH2PO4, pH 7.2, supplemented with 0.3% Tween-20).
Primary antibodies directed against bovine Tg [51] were
diluted 1:1,000 in 2.5% non-fat milk powder and mem-
branes were incubated 90 minutes at RT. Secondary,
horseradish peroxidase (HRP) -coupled antibodies were
allowed to bind for 60 minutes at RT. Immunoreactions
were visualized by enhanced chemiluminescence (ECL)
and imaged on CL-XPosure Clear Blue X-ray films (both
Pierce, PerbioScience, Bonn, Germany) which were
scanned using a transmitted light scanner device (Optic-
Pro ST48, Plustek, Norderstedt, Germany).
N-terminal sequencing of separated Tg fragments
For sequencing, the degradation assays, gel-electrophore-
sis, and blotting were performed as above. The absolute
content of cathepsins and Tg, however, was increased
four-fold. PVDF membranes were briefly washed in
ddH2O and stained overnight with 0.1% Coomassie R250
in 1% acetic acid and 40% methanol. Background was
removed by washing in 50% methanol until bands
became clearly visible. Selected protein bands showing
adequate staining were cut and stored at -20°C until fur-
ther analyzed by automated sequence analyses on a Pro-
cise pulsed-liquid protein sequencer (Applied Biosystems,
Foster City, CA, USA).
Determination of thyroid hormone liberation by fT4-ELISA
To assess the amount of liberated thyroxine, 50 L of the
in vitro degradation samples were analyzed using a com-
mercially available solid phase-based competitive immu-
noassay (DRG Diagnostics, Marburg, Germany). Serum
samples that were included in the ELISA kit and contained
defined fT4-amounts were used as standards. Serum
standards and in vitro degradation samples were assayed
in duplicates and treated equally in all respects. The assay
was conducted according to the manufacturer's recom-
mendation with the performance of optional washes (10
× 5 minutes) with ddH2O. Immediately after addition of
the color reactant the absorbance at 450 nm was read in a
microplate reader (MRX Microplate Reader, Dynatech
Laboratories Inc., Chantilly, VA, USA). The fT4 amount
calculated for blank values was subtracted from individual
samples to accomplish normalization. Data presented are
representative for n = 4 (for endosomal conditions) or n =
3 (for extracellular and lysosomal conditions); errors are
given as standard deviations. Calculations were per-
formed using Origin 7.0 (OriginLab Corporation, North-
ampton, MA, USA).
Immunolocalization of cysteine cathepsins in thyroid tissue
Biopsies of human thyroid tissue were taken from the
non-disease affected regions after thyroidectomy. The use
of human tissue was in compliance with the Helsinki Dec-
laration and was approved to be conducted by WS and KB
by the Ethics Commission of the Ärztekammer Bremen
(Study 120 as of April 18th, 2005) in Germany. Tissue was
fixed in 8% paraformaldehyde in 200 mM Hepes buffer,
pH 7.4, and mounted in tissue freezing medium after sev-
eral buffer exchanges. Cryo-sections were taken with a CM
1900 cryostat (Leica, Bensheim, Germany), and immu-
nolabeled following routine procedures [4,7] with sheep
anti-human cathepsin B (RD Laboratorien, Diessen, Ger-
many), mouse anti-human cathepsin K (IM 55, Oncogene
through Merck Biosciences, Bad Soden, Germany), sheep
anti-human cathepsin L (RD Laboratorien), and rabbit
anti-human cathepsin S (kindly provided by Dr. E. Weber,
Halle, Germany) as primary antibodies, followed by incu-
bation with Alexa 488- or Alexa 546-labeled secondary
antibodies (Molecular Probes through Invitrogen, Karl-
sruhe, Germany). Analysis of mounted tissue was per-
formed by means of confocal laser scanning microscopy
(LSM 510 Meta, Zeiss, Oberkochen, Germany).
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